BHVN
Price
$18.68
Change
+$0.12 (+0.65%)
Updated
Apr 16, 04:59 PM (EDT)
Capitalization
1.89B
23 days until earnings call
FHTX
Price
$3.51
Change
-$0.06 (-1.68%)
Updated
Apr 16, 04:59 PM (EDT)
Capitalization
198.54M
26 days until earnings call
Ad is loading...

BHVN vs FHTX

Header iconBHVN vs FHTX Comparison
Open Charts BHVN vs FHTXBanner chart's image
Biohaven
Price$18.68
Change+$0.12 (+0.65%)
Volume$23K
Capitalization1.89B
Foghorn Therapeutics
Price$3.51
Change-$0.06 (-1.68%)
Volume$651
Capitalization198.54M
BHVN vs FHTX Comparison Chart
Loading...
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BHVN vs. FHTX commentary
Apr 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHVN is a StrongBuy and FHTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 17, 2025
Stock price -- (BHVN: $18.56 vs. FHTX: $3.57)
Brand notoriety: BHVN and FHTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BHVN: 87% vs. FHTX: 60%
Market capitalization -- BHVN: $1.89B vs. FHTX: $198.54M
BHVN [@Biotechnology] is valued at $1.89B. FHTX’s [@Biotechnology] market capitalization is $198.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHVN’s FA Score shows that 0 FA rating(s) are green whileFHTX’s FA Score has 0 green FA rating(s).

  • BHVN’s FA Score: 0 green, 5 red.
  • FHTX’s FA Score: 0 green, 5 red.
According to our system of comparison, BHVN is a better buy in the long-term than FHTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHVN’s TA Score shows that 4 TA indicator(s) are bullish while FHTX’s TA Score has 6 bullish TA indicator(s).

  • BHVN’s TA Score: 4 bullish, 4 bearish.
  • FHTX’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, FHTX is a better buy in the short-term than BHVN.

Price Growth

BHVN (@Biotechnology) experienced а +12.21% price change this week, while FHTX (@Biotechnology) price change was +11.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.99%. For the same industry, the average monthly price growth was -15.53%, and the average quarterly price growth was -25.53%.

Reported Earning Dates

BHVN is expected to report earnings on Aug 04, 2025.

FHTX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+2.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BHVN($1.89B) has a higher market cap than FHTX($199M). FHTX YTD gains are higher at: -24.364 vs. BHVN (-50.308). FHTX has higher annual earnings (EBITDA): -97.17M vs. BHVN (-877.26M). BHVN has more cash in the bank: 486M vs. FHTX (244M). BHVN (36.6M) and FHTX (37.1M) have identical debt. FHTX has higher revenues than BHVN: FHTX (22.6M) vs BHVN (0).
BHVNFHTXBHVN / FHTX
Capitalization1.89B199M952%
EBITDA-877.26M-97.17M903%
Gain YTD-50.308-24.364206%
P/E RatioN/AN/A-
Revenue022.6M-
Total Cash486M244M199%
Total Debt36.6M37.1M99%
FUNDAMENTALS RATINGS
BHVN: Fundamental Ratings
BHVN
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BHVNFHTX
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
74%
Bearish Trend 22 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA254.111.76
+0.70%
Tesla
AAPL202.14-0.38
-0.19%
Apple
SPY537.61-1.51
-0.28%
SPDR® S&P 500® ETF
BTC.X83668.990000-873.398440
-1.03%
Bitcoin cryptocurrency
GME26.70-0.28
-1.04%
GameStop Corp

BHVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BHVN has been loosely correlated with CGON. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BHVN jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHVN
1D Price
Change %
BHVN100%
+0.27%
CGON - BHVN
50%
Loosely correlated
+0.25%
OCUL - BHVN
48%
Loosely correlated
-0.53%
XENE - BHVN
47%
Loosely correlated
-1.23%
RCKT - BHVN
47%
Loosely correlated
+10.49%
IOVA - BHVN
46%
Loosely correlated
-5.28%
More

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with ABOS. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
-0.56%
ABOS - FHTX
52%
Loosely correlated
-4.55%
NAUT - FHTX
52%
Loosely correlated
-1.53%
XNCR - FHTX
50%
Loosely correlated
+6.71%
AVIR - FHTX
48%
Loosely correlated
-4.08%
IMNM - FHTX
48%
Loosely correlated
+0.68%
More